[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Bedaya Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":110},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,45,66,84],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100636717",false,"NCT07569315","Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders","Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders Undergoing IVF Cycle : A Randomized Controlled Study.","Inclusion Criteria:\n\n* GnRH antagonist IVF cycle\n* Hyper-responders to induction of ovulation\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion","FEMALE","18 Years","40 Years",{"count":19,"type":20},190,"ESTIMATED","INTERVENTIONAL",[23],"PHASE2","The aim of this randomized controlled study is to compare the efficacy of three successive doses of a GnRH agonist ( administered 36 , 24 and 12 hours before oocyte retrieval ) with a single dose of a GnRH agonist ( administered 36 hours before oocyte retrieval ) in triggering ovulation in hyper-responders",[26],"Infertility",[26,28,29,30,31],"GnRH agonist trigger","IVF-ET","Hyper-responders","PCOS","NOT_YET_RECRUITING","2026-05-06",{"date":35,"type":36},"2026-05-11","ACTUAL",{"date":38,"type":20},"2026-06-01",{"date":40,"type":20},"2028-04-01",{"name":42,"class":43},"Bedaya Hospital","OTHER",1,{"id":46,"slug":4,"hasResults":10,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":54,"conditions":55,"keywords":56,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":63,"completionDateStruct":64,"leadSponsor":65,"locationsCount":44},"100636715","NCT07569289","Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger","Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger . A Randomized Controlled Study","Inclusion Criteria:\n\n* POSEIDON group 3 and 4\n* GnRH antagonist IVF cycle\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion",{"count":52,"type":20},164,[23],"The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \\[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \\] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation",[26],[26,57,29,58,59,60],"Poor responders","HCG","GnRH agonist","Double trigger","2026-04-29",{"date":33,"type":36},{"date":38,"type":20},{"date":40,"type":20},{"name":42,"class":43},{"id":67,"slug":4,"hasResults":10,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":4,"eligibilityCriteria":71,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":72,"targetDuration":4,"studyType":21,"phases":74,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":80,"startDateStruct":81,"completionDateStruct":82,"leadSponsor":83,"locationsCount":44},"100636716","NCT07569302","Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger","Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger . A Randomized Controlled Study","Inclusion Criteria:\n\n* GnRH antagonist IVF cycle\n* Normo-responders to induction of ovulation\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion",{"count":73,"type":20},196,[23],"The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol \\[a single bolos of HCG combined with two successive doses of a GnRH agonist \\] with HCG \\[a single bolos administered 36 hours before oocyte retrieval \\] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.",[77],"Infertility (IVF Patients)",[26,29,79,59,58],"Normo-responders",{"date":33,"type":36},{"date":38,"type":20},{"date":40,"type":20},{"name":42,"class":43},{"id":85,"slug":4,"hasResults":10,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":4,"eligibilityCriteria":89,"healthyVolunteers":10,"sex":15,"minAge":90,"maxAge":91,"enrollmentInfo":92,"targetDuration":4,"studyType":21,"phases":94,"briefSummary":95,"conditions":96,"keywords":97,"overallStatus":100,"whyStopped":4,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},"100532384","NCT06212102","Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation","Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation: A Randomized Controlled Non-inferiority Trial","Inclusion Criteria:\n\nPatients belonging to Poseidon group 4\n\nExclusion Criteria:\n\n* PCOS\n* Endometriosis\n* History of recurrent abortion","35 Years","44 Years",{"count":93,"type":20},120,[23],"The aim of this randomized controlled trial is to compare the efficacy and cost-effectiveness of using progestin with GnRH antagonist to prevent premature LH surge in poor responders undergoing double stimulation protocol.",[26],[26,29,98,99],"Poor ovarian responders","Double stimulation","RECRUITING","2026-04-28",{"date":103,"type":36},"2026-05-04",{"date":105,"type":36},"2024-05-08",{"date":107,"type":20},"2027-08-01",{"name":42,"class":43},2,""]